Acquired hemophilia A (AHA) is a rare disease resulting from autoantibodies (inhibitors)
against endogenous factor VIII (FVIII) that leads to bleeding, which is often spontaneous and …

ABSTRACT Objectives: Acquired hemophilia A (AHA) is a rare, but potentially life-
threatening, bleeding disorder caused by an autoantibody against factor VIII that interferes …

Acquired hemophilia A (AHA), a rare bleeding disorder caused by neutralizing
autoantibodies against coagulation factor VIII (FVIII), occurs in both men and women without …

Acquired hemophilia A (AHA) is caused by autoantibodies against factor VIII (FVIII).
Immunosuppressive treatment (IST) results in remission of disease in 60% to 80% of …

Although extremely rare, acquired haemophilia A (AHA) can cause severe bleeding, which
may be fatal. The underlying causes of autoantibody development are not fully understood …

Pregnancy induces a number of physiologic changes that affect the hematologic indices,
either directly or indirectly. Recognizing and treating hematologic disorders that occur during …

Acquired haemophilia A (AHA) is a rare but often severe bleeding disorder caused by
autoantibodies against coagulation factor VIII (FVIII). AHA occurs more frequently in the …

Abstract The Spanish Acquired Hemophilia A (AHA) Registry is intended to update the
status of AHA in Spain. One hundred and fifty-four patients were included and …

Autoantibodies affecting the activity or accelerating the clearance of clotting factors
(acquired inhibitors) can develop in patients with autoimmune or malignant disorders, but …

Background Acquired haemophilia A (AHA) is a rare bleeding disorder due to
autoantibodies to coagulation factor VIII that may be secondary to autoimmune diseases …